Select for export TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2017.10.004 PubMed 28987938 Copy citation Copy BibTeX Unknown journal 2017-10-03 Di Giovanni G, De Deurwaerdère P. Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyReview Article Review Article More
Select for export Psychedelic Drugs in Biomedicine. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.tips.2017.08.003 PubMed 28947075 Copy citation Copy BibTeX Unknown journal 2017-09-21 Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pnpbp.2017.09.012 PubMed 28947181 Copy citation Copy BibTeX Unknown journal 2017-09-21 Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T. Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s12954-017-0186-6 PubMed 28870224 Copy citation Copy BibTeX Harm Reduction Journal 2017-09-04 Andersson M, Persson M, Kjellgren A. Europe PMC Published psilocybin Headache / MigraineSafetyAdverse Events Qualitative Study More
Select for export Effect of Psilocybin on Empathy and Moral Decision-Making. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyx047 PubMed 28637246 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2017-08-31 Pokorny T, Preller KH, Kometer M, Dziobek I, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyEmotional ProcessingHealthy Volunteers Other More
Select for export Psychedelic Drugs as Therapeutics: No Illusions About the Challenges. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.776 PubMed 28836272 Copy citation Copy BibTeX Clinical Pharmacology & Therapeutics 2017-08-23 Sellers EM, Leiderman DB. Europe PMC Published psilocybin Safety Other More
Select for export The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-017-4713-7 PubMed 28831571 Copy citation Copy BibTeX Unknown journal 2017-08-22 Sessa B. Europe PMC Published psilocybin Emotional ProcessingSafety Other More
Select for export Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuroimage.2017.07.020 PubMed 28711736 Copy citation Copy BibTeX NeuroImage 2017-07-11 Lewis CR, Preller KH, Kraehenmann R, Michels L, Staempfli P, Vollenweider FX. Europe PMC Published psilocybin Brain ImagingPharmacologyReceptor Pharmacology Other More
Select for export LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/08039488.2017.1336251 PubMed 28678583 Copy citation Copy BibTeX Nordic Journal of Psychiatry 2017-07-04 Larsen JK. Europe PMC Published psilocybin OCDReview ArticleSafety Review Article More
Select for export Potential Therapeutic Effects of Psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s13311-017-0542-y PubMed 28585222 Copy citation Copy BibTeX Unknown journal 2017-06-30 Johnson MW, Griffiths RR. Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-0043-103085 PubMed 28768346 Copy citation Copy BibTeX Unknown journal 2017-06-30 Majić T, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J. Europe PMC Published psilocybin DepressionAnxietyPTSD Other More
Select for export Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881117714049 PubMed 28631526 Copy citation Copy BibTeX Journal of Psychopharmacology 2017-06-19 Forstmann M, Sagioglou C. Europe PMC Published psilocybin AddictionWellbeingPersonality Change Observational Study More
Select for export Psilocybin-assisted therapy for anxiety and depression: implications for euthanasia. No abstract availability was recorded for this entry. Details DOI 10.5694/mja17.00081 PubMed 28918722 Copy citation Copy BibTeX The Medical Journal of Australia 2017-05-31 Strauss N. Europe PMC Published psilocybin DepressionAnxietyRandomized Controlled Trial Randomized Controlled Trial More
Select for export Psilocybin: Good Trip or Bad Trip. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.697 PubMed 28548221 Copy citation Copy BibTeX Clinical Pharmacology & Therapeutics 2017-05-25 Sellers EM. Europe PMC Published psilocybin Pharmacology Other More
Select for export Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2017.1320734 PubMed 28481178 Copy citation Copy BibTeX Unknown journal 2017-05-07 Thomas K, Malcolm B, Lastra D. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/npp.2017.84 PubMed 28443617 Copy citation Copy BibTeX Unknown journal 2017-04-25 Carhart-Harris RL, Goodwin GM. Europe PMC Published psilocybin DepressionBrain ImagingAging Clinical Trial More
Select for export Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/srep46421 PubMed 28422113 Copy citation Copy BibTeX Scientific Reports 2017-04-18 Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD. Europe PMC Published psilocybin ConsciousnessObservational StudyHealthy Volunteers Observational Study More
Select for export Designer Drugs 2.0. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.575 PubMed 28084644 Copy citation Copy BibTeX Unknown journal 2017-01-31 Huestis MA, Tyndale RF. Europe PMC Published psilocybin PTSDPharmacologyReceptor Pharmacology Other More
Select for export Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/03602532.2016.1278228 PubMed 28074670 Copy citation Copy BibTeX Unknown journal 2017-01-30 Dinis-Oliveira RJ. Europe PMC Published psilocybinpsilocin PharmacologyReceptor PharmacologyReview Article Review Article More
Select for export The fibrinolytic system: A new target for treatment of depression with psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.mehy.2017.01.013 PubMed 28236848 Copy citation Copy BibTeX Unknown journal 2017-01-22 Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S. Europe PMC Published psilocybin DepressionNeuroplasticityNeurogenesis Other More
